Investor Relations

Investor Relations

DuoGenic StemCells Corporation (ticker 7607) is listed on the Taipei Exchange Emerging Stock Board (Strategic Board). This page provides financial reports for download and investor FAQs compiled under the Company Act and TPEx Strategic Board rules. Material information is as announced on the Market Observation Post System (MOPS).

Investor FAQ

The company issues no-par-value shares, so its ticker name carries an asterisk: "DuoGenic StemCells*". The questions below explain how no-par-value shares differ in capital recognition, conversion, trading and valuation.

Q1Why does DGSC's stock symbol differ from typical companies?

Per amended regulations, a stock symbol annotated with "*" indicates a company whose shares are no-par-value, or whose par value is not NT$10. As DGSC issues no-par-value shares, our symbol appears as "DuoGenic StemCells*".

Q2What is the difference in capital recognition between no-par-value and par-value shares?

No-par-value shares: certificates record only the number of shares represented, with no face value. Capital is determined at issuance by shares × issue price, and ownership ratio is each shareholder's share count over total shares issued. Par-value shares: certificates record both share count and face value. Capital is determined by shares × par value, and any premium above par is recorded as additional paid-in capital.

Q3Can a no-par-value company convert to par-value shares?

No. Per Article 156-1, Paragraph 6 of the Company Act: "A company that adopts no-par-value shares may not convert to par-value shares." This applies to all public and private companies.

Q4How are shares of a no-par-value company traded and settled?

Trading and settlement procedures are identical to par-value companies. As DGSC is listed on the Taipei Exchange Strategic Board, please refer to TPEx procedures for details.

Q5How should investors evaluate a no-par-value company's stock?

Avoid relying on single financial metrics like EPS or book value per share compared against face value. Instead, use ROE, ROA, dividend yield, P/E ratio, and P/B ratio as reference indicators.